Low-level Laser Therapy as an Adjunct to Non-surgical Periodontal Treatment

Sponsor
University of Beykent (Other)
Overall Status
Completed
CT.gov ID
NCT05233501
Collaborator
(none)
15
1
2
19.9
0.8

Study Details

Study Description

Brief Summary

The present study aimed to investigate the effects of low-level laser therapy (LLLT) as an adjunct to non-surgical periodontal treatment (NSPT) on the plasminogen-activating system in Stage 3-4, Grade C periodontitis patients.

Condition or Disease Intervention/Treatment Phase
  • Procedure: low level laser therapy
  • Procedure: non-surgical periodontal treatment
N/A

Detailed Description

Limited data is available regarding the effects of various periodontal treatment protocols on GCF t-PA and PAI-1 levels, and the extent to which LLLT in conjunction with NSPT affects these levels in patients with Stage 3-4, Grade C periodontitis is unknown. Therefore, this study measured standard clinical outcomes and GCF t-PA and PAI-1 levels in patients with Stage 3-4 Grade, C periodontitis in order to assess the use of LLLT as an adjunct to standard NSPT.

This split-mouth study was conducted with 15 Stage 3-4, Grade C periodontitis patients and 15 healthy individuals matched for age and sex. Participants were grouped as follows: Periodontitis/NSPT (Sham); Periodontitis/NSPT+LLLT (LLLT); Periodontally Healthy (Control). LLLT was applied following NSPT and again on post-treatment Days 2 and 7. Clinical parameters were recorded at baseline (i.e. before NSPT) and on Day 30. Gingival crevicular fluid (GCF) samples were collected at baseline and during follow-up visits on Days 7, 14 and 30. GCF t-PA and PAI-1 levels were measured with ELISA.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
a split-mouth randomized controlled clinical studya split-mouth randomized controlled clinical study
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
The Effect of Low-level Laser Therapy on Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor 1 in Gingival Crevicular Fluid of Stage 3-4, Grade C Periodontitis Patients Received Non-surgical Periodontal Treatment.
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Sep 30, 2017
Actual Study Completion Date :
Aug 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Sham Comparator: non-surgical perıodontal treatment

Procedure: non-surgical periodontal treatment
standart periodontal therapy

Experimental: non-surgical treatment+ low level laser therapy

Procedure: low level laser therapy
adjunctive application of low level laser therapy to non-surgical periodontal treatment

Procedure: non-surgical periodontal treatment
standart periodontal therapy

Outcome Measures

Primary Outcome Measures

  1. the change in GCF tissue plasminogen activator [baseline and during follow-up visits on Days 7, 14 and 30.]

    Gingival crevicular fluid (GCF) samples were collected before SRP treatment and on days 7, 14 and 30 of follow- up and the change of the related mediator at those time points. The Amount of the related mediator were evaluated using enzyme- linked immunosorbent assay [ELISA] kit. Total amounts (pg/30 s) of the mediator collected from each sample in a 30- second period were calculated and recorded for analysis.

  2. the change in GCF plasminogen activator inhibitor 1 [baseline and during follow-up visits on Days 7, 14 and 30.]

    Gingival crevicular fluid (GCF) samples were collected before SRP treatment and on days 7, 14 and 30 of follow- up and the change of the related mediator at those time points. The Amount of the related mediator were evaluated using enzyme- linked immunosorbent assay [ELISA] kit. Total amounts (pg/30 s) of the mediator collected from each sample in a 30- second period were calculated and recorded for analysis.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Stage 3-4, Grade C periodontitis (at least one site with probing depth (PD) and clinical attachment level (CAL) ≥5 mm in their incisors and/or first molars and at least 6 other teeth with similar PD and CAL measurements, with alveolar bone loss confirmed by radiography; familial aggregation;

  • presence of ≥16 teeth;

  • no periodontal treatment in the 6 months prior to data collection;

  • non-smoker

Exclusion Criteria:
  • systemic problems, including a medical history of cancer, rheumatoid arthritis, diabetes mellitus, or cardiovascular disease;

  • compromised immune system;

  • pregnancy, menopause, or lactation;

  • ongoing drug therapy that might affect the clinical characteristics of periodontitis;

  • use of systemic antimicrobials during the 6 weeks prior to data collection

Contacts and Locations

Locations

Site City State Country Postal Code
1 Beykent University Istanbul Turkey

Sponsors and Collaborators

  • University of Beykent

Investigators

  • Principal Investigator: Ferda Pamuk Özer, Beykent University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ferda Pamuk Özer, Associate professor, University of Beykent
ClinicalTrials.gov Identifier:
NCT05233501
Other Study ID Numbers:
  • interventional
First Posted:
Feb 10, 2022
Last Update Posted:
Feb 10, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ferda Pamuk Özer, Associate professor, University of Beykent
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2022